Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The same advanced technology that distinguished Percept™ PC neurostimulator is now available in a rechargeable version specifically designed to be small, smart and adaptive.
Download Percept™ family brochureComfortable
The Percept™ neurostimulators are designed to have a low profile under your skin for your comfort and for minimal visibility of the implanted device.
Rapid recharging
Ready for future advancements
You won’t need to replace your Percept™ neurostimulator to upgrade your therapy when software advancements become available.
John, from the UK, is living well with Medtronic deep brain stimulation therapy for Parkinson's disease.
He explains that DBS helped with his movement and how that makes him feel much more confident.
7 out of 10
DBS-eligible patients with movement disorders may need an MRI within 10 years of receiving their device.7
Unlike other DBS systemsc, the Percept™ neurostimulators are compatible with 3T and 1.5T MRI scans for when you need high-quality imaging.
For your comfort, Medtronic DBS therapy can also remain on while you’re getting an MRI (under certain conditions).b
Medtronic. NDHF1530-195093: Created on Nov. 18, 2022; Version 9.0
Medtronic. NDHF1530-207884: Created on Aug. 30, 2021; Version 2.0
Medtronic. NDHF1598-208892: Created on April 18, 2023; Version 4.0
MRI guidelines for Medtronic deep brain stimulation systems. Medtronic; Medtronic 2020.
Abbott. MRI scans with deep brain stimulation: how to prepare for your MRI scan. 2023. Accessed on October 31, 2023.
ImageReady™ MRI guidelines for Boston Scientific deep brain stimulation systems. Boston Scientific, 2022.
Falowski S, Safriel Y, Ryan MP, Hargens L. The rate of magnetic resonance imaging in patients with deep brain stimulation. Stereotact Funct Neurosurg. 2016;94(3):147-53. doi: 10.1159/000444760.
Medtronic. NDHF1588-201209: Created on March 21, 2023; Version 4.0
Medtronic. NDHF1245-144685: Created on May 16, 2019; Version 7.0
Medtronic. NDHF1598-212345: Created on June 23, 2023; Version 3.0
Medtronic. NDHF1598-196706: Created on Oct. 11, 2021; Version 7.0
Medtronic. NDHF1598-200549: Created on Aug. 1, 2023; Version 13.0
Medtronic. NDHF1598-210255: Created on July 22, 2022; Version 4.0
Medtronic. NDHF1530-215157: Created on May 13, 2022; Version 2.0
Schuepbach WMM, Rau J, Knudsen K, Volkmann J, Krack P, Timmermann L, et al. Neurostimulation for Parkinson’s Disease with Early Motor Complications. N Engl J Med 2013 Feb 13;368(7):610-22
Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. NEngl J Med. 2006;355(9):896-908.
a. For implant depths of up to 2.0 cm. Based on appropriate charger placement.
b. Under specific conditions. Refer to product labeling for full list of conditions: manuals.medtronic.com/manuals/mri/region
c. Abbott ™* and Boston Scientific ™* DBS systems are 1.5T MR conditional and stimulation and cannot remain on during an MRI scan. ImageReady ™* MRI Guidelines for Boston Scientific Deep Brain Stimulation Systems MP92438760-05 Rev A, accessed December 18, 2023. Abbott MRI Support DBS Full Systems, accessed December 18, 2023
d. As compared to Boston Scientific Vercise Genus™* R16 and Vercise Genus™* P16. MP92328632-05 REV-A. As compared to St. Jude Medical Infinity™* 5/7 IPG. ARTEN600150429 - B.
e. Weekly recharge means full depletion and recharge of the battery 0% to 100% every week.
Information contained herein is not medical advice and should not be used as an alternative to speaking with your doctor. Discuss indications, contraindications, warnings, precautions, adverse events and any further information with your health care professional. Medtronic does not assume any liability for completeness and correction of the information contained herein. Please refer to the information of use for further information on the use and handling of the product, risks and benefits.